---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-084024"
form_type: "8-K/A"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2024-07-17T23:59:59+00:00"
generated_at: "2026-05-31T20:08:33.121057+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics files Charter Amendment for 1-for-10 reverse stock split effective July 17, 2024

## Summary
- Reverse stock split at ratio 1-for-10; effective July 17, 2024 at 5:00 p.m. ET.
- Every 10 pre-split shares automatically converted to 1 post-split share; par value unchanged.
- Stock continues trading on Nasdaq under symbol TCRT; new CUSIP number 98973P309 effective July 18.
- Stockholders approved reverse split at June 6, 2024 annual meeting; board set final ratio on June 26, 2024.
- Equiniti Trust Company appointed as exchange agent for the split.

## SEC filing metadata
- accession: 0000950170-24-084024
- form_type: 8-K/A
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2024-07-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 9.01, 3.03, 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000095017024084024/0000950170-24-084024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000095017024084024/tcrt-20240716.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-084024
- JSON: https://secwatch.observer/filing/0000950170-24-084024.json
- Plain text: https://secwatch.observer/filing/0000950170-24-084024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.